Synonyms: leocaine; Amethocaine; Tetrracaine Hydrochloride; BG0334; CCG-39266; FC1267; GK4286; NSC757337; s2573; Tetracaine hydrochloride (JP17/USP); AKOS015888160; Tox21_110290_1; AN-6593; Tetracaine hydrochloride; API0004370; CS-2587; KS-5059; LP01211; NSC-757337; NCGC00016049-07; NCGC00094458-01; NCGC00094458-02; NCGC00094458-03; NCGC00094458-04; 136-47-0; NCGC00094458-05; NCGC00261896-01; 53762-93-9; BC204037; H770; LS-36314; AB0005064; AB1007071; EU-0101211; FT-0603346; Tetracaine HCl; SW196411-3; D00741; K-4359; T 7508; 136T470; A807078; C-18782; Tetracaine hydrochloride, Sigma Reference Standard; 4-butylaminobenzoic acid dimethylaminoethyl ester hcl; I01-0381; Butethanol; SR-01000075240-1; SR-01000075240-6; 2-dimethylaminoethyl 4-(butylamino)benzoate hydrochloride; 2-Dimethylaminoethyl 4-n-butylaminobenzoate hydrochloride; Tetracaine hydrochloride, meets USP testing specifications; 2-(Dimethylamino)ethyl 4-(n-Butylamino)benzoate Hydrochloride; 2-dimethylaminoethyl ester ofp-butylaminobenzoic acid hydrochloride; Tetracaine Hydrochloride 1.0 mg/ml in Acetonitrile (as free base); 4-(n-Butylamino)benzoic Acid 2-(Dimethylamino)ethyl Ester Hydrochloride; Tetracaine hydrochloride, European Pharmacopoeia (EP) Reference Standard; Amethocaine hydrochloride; Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester,monohydrochloride; Tetracaine for system suitability, European Pharmacopoeia (EP) Reference Standard; Tetracaine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Tetracaine hydrochloride, United States Pharmacopeia (USP) Reference Standard; 2-Dimethylaminoethyl 4-n-butylaminobenzoate hydrochloride; 4-(Butylamino)benzoic acid 2-(dimethylamino)ethyl ester hydrochloride; Niphanoid; Dicaine; Dikain; tetracaine; Pontocaine; Butylocaine; Mixture Name; Fulvidex (Veterinary); Tetracaine hydrochloride; C15H24N2O2.ClH; CID8695; C15-H24-N2-O2.Cl-H; ACN-028625; B1413; T1688; 4-(Butylamino)benzoic acid 2-(dimethylamino)ethyl ester; Anethain; 4-(Butylamino)benzoic acid 2-(dimethylamino)ethyl ester monohydrochloride; Tetracaine hydrochloride, 98%, a potent local anaesthetic and a channel function allosteric inhibitor - 25G 25g; Anethaine; Curtacain; Ametop; Decicain; Decicaine; Dessicain; Dicainum; Intercaine; Leocaine; Menonasal; Pantocain; Pantocaine; Tonexol; Dicaine; Anacel; Gingicain M; Tetracaine (hydrochloride); Tetracainium chloridum; Tetracaine chlorhydrate; 2-(dimethylamino)ethyl 4-(butylamino)benzoate hydrochloride; UNII-5NF5D4OPCI; Tetracaine monohydrochloride; Amethocaine monohydrochloride; EINECS 205-248-5; Hydrochloride, Tetrracaine; 5NF5D4OPCI; 4-(Butylamino)benzoic Acid 2-(Dimethylamino)ethyl Ester Hydrochloride; Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester, monohydrochloride; MLS000069780; 2-(Dimethylamino)ethyl p-(butylamino)benzoate monohydrochloride; MFCD00038912; Tetracaine hydrochloride (Pontocaine); Amethocaine HCl; p-Butylaminobenzoyl-2-dimethylaminoethanol hydrochloride; 2-Dimethylaminoethanol 4-N-butylaminobenzoate hydrochloride; Pantocaine; 2-(Dimethylamino)ethyl p-(butylamino)benzoate hydrochloride; SMR000058522; p-(Butylamino)benzoic acid, 2-(dimethylamino)ethyl ester, hydrochloride; DSSTox_CID_22448; DSSTox_RID_80027; DSSTox_GSID_42448; Q-201806; Viractin; 4-[Butylamino]benzoic acid-2-[dimethylamino]ethyl ester hydrochloride; BENZOIC ACID, p-(BUTYLAMINO)-, 2-(DIMETHYLAMINO)ETHYL ESTER, MONOHYDROCHLORIDE; Pontocaine; C15H24N2O2; SR-01000075240; NCGC00016049-02; CAS-136-47-0; 2-(dimethylamino)ethyl 4-(butylamino)benzoate;hydrochloride; Exactacain; Amethocalne HCl; Tetracaine, HCl; Tetracaine hydrochloride [USP:JAN]; Tetracaine hydrochloride [USAN:JAN]; Tetracaine; tetracainehydrochloride; intercain hydrochloride; meethobalm hydrochloride; Pontocaine Hydrochloride; Tetracaine hydrochloride/; AC1L1RIV; l and ocain hydrochloride; Opera_ID_1220; SCHEMBL24370; C15H25ClN2O2; Tetracaine Monohydrochloride; MLS002222164; Protocaine hydrochloride (TN); SPECTRUM1500564; CHEBI:9469; CHEMBL1255654; DTXSID6042448; PPWHTZKZQNXVAE-UHFFFAOYSA-N; Tetracaine hydrochloride, >=99%; tetracaine-hydrochloride-pontocaine; HMS1569D04; Tetrakain; HMS1921C17; Pharmakon1600-01500564; ACT04762; BCP26339; EBD43387; HY-B0473; Tox21_110290; Tox21_501211; ABP000722; AC-774;